Skip to content

Evaluation of Safety of Filler Injection in Subcutaneous Tissues

A Single-Arm Pilot Study to Evaluate the Safety of Adipearl Injection in the Subcutaneous Tissues of Adults

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06322043
Enrollment
18
Registered
2024-03-20
Start date
2024-03-26
Completion date
2025-10-30
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Face Volume Deficiency

Brief summary

Adipearl is an injectable filler intended to be injected subcutaneously.

Interventions

DEVICEAdipearl

Injection of the investigational device in subcutaneous tissue.

Sponsors

Volumina Medical S.A.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject having given freely and expressly informed consent; * Subject deemed by the Investigator to be medically fit for injection of the product; * Female or male subjects aged 22 to 65 years (inclusive);

Exclusion criteria

* Pregnant or nursing woman or planning a pregnancy during the study. * Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship. * Subject participating to another research study. * Subject with the presence of any condition, which in the opinion of the Principal Investigator, that makes her/him unable to complete the study per protocol.

Design outcomes

Primary

MeasureTime frameDescription
Safety of Investigational Medical Device6-MonthsCollection of Injection Site Reactions and Adverse Events during the study.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026